26m agoThe FlyBULLISH 64Earnings
Why Is ZEVRA THERAPEUTICS I (ZVRA) Stock Moving Today?
By the Top Tier Newswire AI Desk · August 24, 2026 at 9:21 AM ET · reviewed against 5 wire stories
ZEVRA THERAPEUTICS I (ZVRA) is drawing unusual attention today. Our newswire has captured 5 stories on ZVRA across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
ZVRA stock is moving modestly higher in the early minutes of trading after Zevra Therapeutics announced inducement grants under Nasdaq Listing Rule 5635(c)(4). The stock opened at $12.05, a 1.5% gap up from the previous close of $11.87. The session has seen no intraday movement, with the price remaining at $12.05. The company’s announcement of equity inducement grants is the primary driver of the early upward gap.
What Happened
Zevra Therapeutics disclosed the inducement grants, which are standard corporate actions used to attract and retain key personnel under Nasdaq rules. The move aligns with the company’s ongoing strategy to strengthen its leadership and development teams as it advances its commercial-stage therapeutic programs for rare diseases. The announcement was made in a press release filed with Globe NewsWire on August 21, 2026. This development follows a recent update from Zevra stating its intent to continue engagement with the U.S. FDA in the second half of 2026 to explore pathways for accelerating clinical development.
What The Data Shows
Zevra Therapeutics has a market cap of $704.9 million and a P/E ratio of 12.4. The company’s revenue has grown by 119.4% in the trailing twelve months, with a net margin of 42.8%. The stock has traded between $7.16 and $15.04 over the past 52 weeks. On August 24, the stock printed five fresh 52-week highs and eight fresh 52-week lows, indicating a volatile trading pattern. Recent insider transactions show three sales totaling $1.1 million in the last 90 days, with the most recent filing on August 17.
What To Watch
Zevra Therapeutics is expected to continue its engagement with the FDA in the second half of 2026. Investors should monitor the breadth of analyst coverage and any updates on clinical development pathways as key indicators of future momentum.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ZVRA by the numbers
Coverage: 5 stories / 4 sourcesAI sentiment: 58/100 (bullish)Mkt cap: $705MP/E: 12.452w: $7.16 to $15.04
The headlines behind the move
44m agoSeeking AlphaBULLISH 74Earnings
Zevra Therapeutics, Inc. GAAP EPS of $0.26 beats by $0.11, revenue of $37.8M beats by $0.39M
Zevra Therapeutics Q3 earnings beat estimates as revenue jumped 44.8% year over year.
1h agoSEC 8-KNEUTRAL 50General
ZEVRA THERAPEUTICS, INC. (ZVRA) files 8-K
Filed: 2026-11-03 AccNo: 0001434647-26-000085 Size: 321 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
1h agoStockTitanNEUTRAL 50Earnings
Zevra Reports Third Quarter 2026 Financial Results and Corporate Update
$37.8 million net revenue for Q3 2026 , driven by $34.0 million in revenue from MIPLYFFA
1h agoThe FlyNEUTRAL 50Earnings
Zevra Therapeutics Inc options imply 10.4% move in share price post-earnings
Frequently asked questions
Why is ZVRA stock moving today?
ZEVRA THERAPEUTICS I (ZVRA) is drawing unusual attention today. Our newswire has captured 5 stories on ZVRA across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "Zevra Therapeutics reports Q3 EPS 26c, consensus 18c" (The Fly).
Is ZVRA a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ZVRA coverage reads 58/100 over 5 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is STVN down today (-28.57%)
- Why is AEHR up today (+26.50%)
- Why is CLVT up today (+25.90%)
- Why is GPK up today (+21.22%)
- Why is IBTA up today (+20.53%)
- Why is RIOT up today (+18.41%)
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ZVRA: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ZVRA move explainers: 2026-08-24